TABLE 4.
Australia | Canada | England | France | Germany | Netherlands | New Zealand | Spain | Sweden | Switzerland | United States | |
---|---|---|---|---|---|---|---|---|---|---|---|
Sample size | 3014 | 6305 | 742 | 21,957 | 10,583 | 2035 | 1572 | 1270 | 4615 | 3369 | 21,803 |
Age | |||||||||||
Mean (SD) | 79.4 (6.8) | 78.1 (7.0) | 78.7 (6.6) | 79.1 (6.9) | 79.0 (6.4) | 76.2 (5.6) | 77.3 (6.9) | 80.2 (5.1) | 80.3 (6.8) | 78.6 (6.5) | 77.2 (7.0) |
Median | 80 | 79 | 79 | 80 | 79 | 77 | 77 | 81 | 81 | 77 | 77 |
Proportion female | 36.5% | 45.4% | 42.5% | 46.0% | 50.7% | 48.4% | 42.4% | 46.9% | 41.3% | 42.6% | 50.0% |
Chronic conditions | |||||||||||
Mean (SD) | 5.9 (2.3) | 3.5 (1.3) | 5.1 (1.5) | 6.8 (2.5) | 6.1 (2.0) | n/a | 3.9 (1.4) | 5.6 (2.1) | 3.2 (1.2) | 5.9 (1.7) | 6.3 (1.7) |
Median | 6 | 3 | 5 | 5 | 6 | n/a | 4 | 5 | 3 | 6 | 6 |
Chronic conditions | |||||||||||
Heart failure | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
Diabetes | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
Depression | 4.0% | 1.5% | 3.5% | 4.7% | 6.3% | n/a | 0.4% | 6.6% | 1.0% | 8.0% | 1.5% |
Hypertension | 51.6% | 41.1% | 64.2% | 69.0% | 82.4% | n/a | 51.2% | 75.7% | 57.2% | 81.2% | 89.3% |
Renal failure | 49.3% | 5.5% | 39.2% | 34.9% | 59.0% | n/a | 47.3% | 42.9% | 25.8% | 62.1% | 54.5% |
Chronic obstructive pulmonary disease | 26.2% | 16.3% | 31.0% | 17.1% | 22.7% | n/a | 10.3% | 24.6% | 18.7% | 17.7% | 42.7% |
Note: The Netherlands was unable to identify Elixhauser conditions in the data provided by the insurer. Clinical experts were used to identify the relevant codes in the insurer data that matched the primary diagnoses of interest.